Filing Details
- Accession Number:
- 0001127602-15-009820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 20:55:44
- Reporting Period:
- 2015-03-02
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 20:55:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185858 | David Baltimore | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-02 | 3,647 | $158.76 | 31,159 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported is an average price. The prices ranged from $158.74 to $158.791 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
Billionaire Hedge Funds
